NSEUpdates11 Aug 2026 · 11 Aug 2026, 07:07 pm

Updates

Zydus Lifesciences Limited · ZYDUSLIFE

✦ AI SummaryRegulatory

Zydus Lifesciences Limited has reported a violation of the SEBI (Prohibition of Insider Trading) Regulations, 2015, by one of its Designated Persons, Mr. Ashutosh Patil, who traded in the company's equity shares without adhering to the Code of Conduct.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern2/10
Regulatory Risk8/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Zydus Lifesciences Limited has informed the Exchange regarding 'Reporting of violation of Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015'.

Attachments (1)

📄

Cadilahc_11082026190609_SEIntimation11082026.pdf

pdf

Download →
View document text
August 11, 2026 Listing Department Code: 532321 BSE LIMITED P. J. Towers, Dalal Street, Mumbai–400 001 Listing Department Code: Zyduslife NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, C/1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai–400 051 Sub: Reporting of violation of Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015 (“SEBI PIT Regulations”) Ref: SEBI circular No. SEBI/HO/ISD/ISD/CIR/P/2020/135 dated July 23, 2020 Dear Sir, In terms of SEBI circular no. SEBI/HO/ISD/ISD/CIR/P/2020/135 dated July 23, 2020 ("SEBI Circular") with respect to reporting to the Stock Exchanges regarding violations under SEBI PIT Regulations relating to the Code of Conduct (“CoC”), please find attached herewith report of the Company for violation of CoC by a Designated Person. Details of the violation are provided in Annexure-“A” attached herewith. Kindly take note of the same. Thanking you, Yours faithfully, For, ZYDUS LIFESCIENCES LIMITED DHAVAL N. SONI COMPANY SECRETARY & COMPLIANCE OFFICER MEMBERSHIP NO. FCS7063 Annexure-“A” Report by Zydus Lifesciences Limited for violations related to Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015 Sr. No. Particulars Details 1. Name of the listed company/ Zydus Lifesciences Limited Intermediary/Fiduciary 2. Please tick appropriate checkbox Listed Company Reporting in capacity of : ☐ Listed Company ☐ Intermediary ☐ Fiduciary 3. A. Details of Designated Person (DP) i. Name of the DP Mr. Ashutosh Patil ii. PAN of the DP EEKPP9093G iii. Designation of DP Associate Research Scientist iv. Functional Role of DP Project Manager v. Whether DP is Promoter or belongs to No Promoter Group B. If Reporting is for immediate relative of DP i. Name of the immediate relative of DP Not Applicable ii. PAN of the immediate relative of DP Not Applicable C. Details of transaction(s) i. Name of the scrip NSE Symbol: Zyduslife BSE Symbol: 532321 ii. No of shares traded and value (Rs.) (Date- Purchase and sell of 171 equity wise) shares on March 11, 2026, and May 22, 2026, respectively. The value of shares traded is Rs. 3,36,166/- only. D. In case value of trade(s) is more than Rs. 10 lacs in a calendar quarter i. Date of intimation of trade(s) by concerned DP Not applicable / director / promoter / promoter group to Company under regulation 7 of SEBI (PIT) Regulations, 2015 ii. Date of intimation of trade(s) by Company to Not applicable stock exchanges under regulation 7 of SEBI (PIT) Regulations, 2015 4. Details of violations observed under Code of Mr. Ashutosh Patil-Designated Conduct Person has inadvertently traded (contra trade) in equity shares of the Company and hence it is considered as violation of regulation 9 read with clause 10 of Schedule B of SEBI PIT Regulations and the CoC adopted by the Company. 5. Action taken by Listed company/ Intermediary/ The Company has issued a warning Fiduciary letter to Mr. Ashutosh Patil- Designated Person to strictly adhere to the provisions of the SEBI PIT Regulations and CoC and also to remain diligent and be in complete compliance with the CoC henceforth to avoid any actions for any subsequent violations. Accordingly, Mr. Ashutosh Patil has provided apology letter for trading (contra trade) in equity shares of the Company. 6. Reasons recorded in writing for taking action He has admitted that the trade stated above executed was purely unintentional and due to oversight. 7. Details of the previous instances of violations, if No previous instances of violation any, since last financial year are observed. 8. If any amount collected for Code of Conduct violation(s): An amount of Rs. 18,797/- being the profit gained by Mr. Ashutosh Patil, by entering into contra trade, is transferred online by him directly to IEPF. i. Mode of transfer to SEBI - IPEF Online (Online/Demand Draft) ii. Details of transfer/payment In case of Online: Particulars Details Name of the Ashutosh Patil transferor Bank Name, ICICI Bank, branch and Residency Road, Account number Branch, Bangaluru Account No. 742901500565 UTR/Transaction 260810281845192 reference Number Transaction date August 10, 2026 Transaction Rs. 18797/- Amount (in Rs.) In case of Demand Draft (DD): Not applicable Particulars Details Bank Name and branch DD Number DD date Transaction date DD amount (in Rs.) 9. Any other relevant information The Audit Committee at its meeting held on August 11, 2026, took note of the same. Yours faithfully, For, ZYDUS LIFESCIENCES LIMITED DHAVAL N. SONI COMPANY SECRETARY & COMPLIANCE OFFICER PAN: BEWPS0561P Email id: dhavalsoni@zyduslife.com Date: August 11, 2026 Place: Ahmedabad